Table of Content

1 Peptide CDMO Market Introduction and Overview
1.1 Peptide CDMO Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Peptide CDMO Sales and Market Share by Manufacturer
2.2 Global Peptide CDMO Revenue and Market Share by Manufacturer
2.3 Global Peptide CDMO Average Price by Manufacturers
2.4 Manufacturers Peptide CDMO Production Sites, Area Served, Product Type
2.5 Peptide CDMO Market Competitive Situation and Trends
2.5.1 Peptide CDMO Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.5.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Bachem
3.1.1 Bachem Company Profile
3.1.2 Peptide CDMO Product Overview
3.1.3 Bachem Peptide CDMO Market Performance (2018-2023)
3.1.4 Bachem Business Overview
3.2 PolyPeptide
3.2.1 PolyPeptide Company Profile
3.2.2 Peptide CDMO Product Overview
3.2.3 PolyPeptide Peptide CDMO Market Performance (2018-2023)
3.2.4 PolyPeptide Business Overview
3.3 CordenPharma
3.3.1 CordenPharma Company Profile
3.3.2 Peptide CDMO Product Overview
3.3.3 CordenPharma Peptide CDMO Market Performance (2018-2023)
3.3.4 CordenPharma Business Overview
3.4 AmbioPharm
3.4.1 AmbioPharm Company Profile
3.4.2 Peptide CDMO Product Overview
3.4.3 AmbioPharm Peptide CDMO Market Performance (2018-2023)
3.4.4 AmbioPharm Business Overview
3.5 USV Peptides
3.5.1 USV Peptides Company Profile
3.5.2 Peptide CDMO Product Overview
3.5.3 USV Peptides Peptide CDMO Market Performance (2018-2023)
3.5.4 USV Peptides Business Overview
3.6 Thermofischer
3.6.1 Thermofischer Company Profile
3.6.2 Peptide CDMO Product Overview
3.6.3 Thermofischer Peptide CDMO Market Performance (2018-2023)
3.6.4 Thermofischer Business Overview
3.7 Bio Basic
3.7.1 Bio Basic Company Profile
3.7.2 Peptide CDMO Product Overview
3.7.3 Bio Basic Peptide CDMO Market Performance (2018-2023)
3.7.4 Bio Basic Business Overview
3.8 JPT
3.8.1 JPT Company Profile
3.8.2 Peptide CDMO Product Overview
3.8.3 JPT Peptide CDMO Market Performance (2018-2023)
3.8.4 JPT Business Overview
3.9 Genscript
3.9.1 Genscript Company Profile
3.9.2 Peptide CDMO Product Overview
3.9.3 Genscript Peptide CDMO Market Performance (2018-2023)
3.9.4 Genscript Business Overview
3.10 Xinbang Pharma
3.10.1 Xinbang Pharma Company Profile
3.10.2 Peptide CDMO Product Overview
3.10.3 Xinbang Pharma Peptide CDMO Market Performance (2018-2023)
3.10.4 Xinbang Pharma Business Overview
3.11 ScinoPharm
3.11.1 ScinoPharm Company Profile
3.11.2 Peptide CDMO Product Overview
3.11.3 ScinoPharm Peptide CDMO Market Performance (2018-2023)
3.11.4 ScinoPharm Business Overview
3.12 SN Biopharm
3.12.1 SN Biopharm Company Profile
3.12.2 Peptide CDMO Product Overview
3.12.3 SN Biopharm Peptide CDMO Market Performance (2018-2023)
3.12.4 SN Biopharm Business Overview
3.13 CBL
3.13.1 CBL Company Profile
3.13.2 Peptide CDMO Product Overview
3.13.3 CBL Peptide CDMO Market Performance (2018-2023)
3.13.4 CBL Business Overview
3.14 Piramal Pharma
3.14.1 Piramal Pharma Company Profile
3.14.2 Peptide CDMO Product Overview
3.14.3 Piramal Pharma Peptide CDMO Market Performance (2018-2023)
3.14.4 Piramal Pharma Business Overview
3.15 CPC Scientific
3.15.1 CPC Scientific Company Profile
3.15.2 Peptide CDMO Product Overview
3.15.3 CPC Scientific Peptide CDMO Market Performance (2018-2023)
3.15.4 CPC Scientific Business Overview
4 Global Peptide CDMO Historical and Forecast Market Analysis by Type
4.1 Market Size Analysis by Types
4.2 Global Peptide CDMO Revenue and Market Share by Type
4.3 Global Peptide CDMO Sales and Market Share by Type
4.4 Global Peptide CDMO Revenue Market Forecast by Type (2023-2029)
4.5 Global Peptide CDMO Sales Market Forecast by Type (2023-2029)
5 Global Peptide CDMO Historical and Forecast Market Analysis by Application
5.1 Market Size Analysis by Application
5.2 Global Peptide CDMO Revenue Market Share by Application (2018-2023)
5.3 Global Peptide CDMO Sales Market Share by Application (2018-2023)
5.4 Peptide CDMO Revenue Market Forecast by Application (2023-2029)
5.5 Peptide CDMO Sales Market Forecast by Application (2023-2029)
6 Global Peptide CDMO Market Production Growth Trends Analysis
6.1 Global Peptide CDMO Market Size & Forecast (2018-2029)
6.2 Peptide CDMO Growth Trends Analysis by Regions
6.2.1 Peptide CDMO Production Market Size by Regions: 2018 VS 2023 VS 2029
6.2.2 Peptide CDMO Historic Market Size by Regions (2018-2023)
6.2.3 Peptide CDMO Forecasted Market Size by Regions (2023-2029)
6.2.4 North America Peptide CDMO Production & Forecast (2018-2029)
6.2.5 Europe Peptide CDMO Production & Forecast (2018-2029)
6.2.6 China Peptide CDMO Production & Forecast (2018-2029)
6.2.7 Japan Peptide CDMO Production & Forecast (2018-2029)
6.2.8 Korea Peptide CDMO Production & Forecast (2018-2029)
6.2.9 Southeast Asia Peptide CDMO Production & Forecast (2018-2029)
6.2.10 India Peptide CDMO Production & Forecast (2018-2029)
6.2.11 South America Peptide CDMO Production & Forecast (2018-2029)
6.2.12 Middle East & Africa Peptide CDMO Production & Forecast (2018-2029)
7 Global Market Growth Trends Analysis
7.1 Global Peptide CDMO Market Size & Forecast (2018-2029)
7.2 Peptide CDMO Growth Trends Analysis by Regions
7.2.1 Peptide CDMO Consumption Market Size by Regions: 2018 VS 2023 VS 2029
7.2.2 Peptide CDMO Historic Market Size by Regions (2018-2023)
7.2.3 Peptide CDMO Forecasted Market Size by Regions (2023-2029)
7.2.4 North America Peptide CDMO Consumption & Forecast (2018-2029)
7.2.5 Europe Peptide CDMO Consumption & Forecast (2018-2029)
7.2.6 China Peptide CDMO Consumption & Forecast (2018-2029)
7.2.7 Japan Peptide CDMO Consumption & Forecast (2018-2029)
7.2.8 Korea Peptide CDMO Consumption & Forecast (2018-2029)
7.2.9 Southeast Asia Peptide CDMO Consumption & Forecast (2018-2029)
7.2.10 India Peptide CDMO Consumption & Forecast (2018-2029)
7.2.11 South America Peptide CDMO Consumption & Forecast (2018-2029)
7.2.12 Middle East & Africa Peptide CDMO Consumption & Forecast (2018-2029)
8 North America
8.1 North America Peptide CDMO Consumption by Types
8.2 North America Peptide CDMO Consumption by Applications
8.3 North America Peptide CDMO Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
9 Europe
9.1 Europe Peptide CDMO Consumption by Types
9.2 Europe Peptide CDMO Consumption by Applications
9.3 Europe Peptide CDMO Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
10 China
10.1 China Peptide CDMO Consumption by Types
10.2 China Peptide CDMO Consumption by Applications
10.3 China Peptide CDMO Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
11 Japan
11.1 Japan Peptide CDMO Consumption by Types
11.2 Japan Peptide CDMO Consumption by Applications
11.3 Japan Peptide CDMO Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
12 Korea
12.1 Korea Peptide CDMO Consumption by Types
12.2 Korea Peptide CDMO Consumption by Applications
12.3 Korea Peptide CDMO Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
13 Southeast Asia
13.1 Southeast Asia Peptide CDMO Consumption by Types
13.2 Southeast Asia Peptide CDMO Consumption by Applications
13.3 Southeast Asia Peptide CDMO Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
14 India
14.1 India Peptide CDMO Consumption by Types
14.2 India Peptide CDMO Consumption by Applications
14.3 India Peptide CDMO Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
15 South America
15.1 South America Peptide CDMO Consumption by Types
15.2 South America Peptide CDMO Consumption by Applications
15.3 South America Peptide CDMO Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
16 Middle East & Africa
16.1 Middle East & Africa Peptide CDMO Consumption by Types
16.2 Middle East & Africa Peptide CDMO Consumption by Applications
16.3 Middle East & Africa Peptide CDMO Consumption, Price, Revenue, Gross and Gross Margin (2018-2023)
17 Peptide CDMO Manufacturing Cost Analysis
17.1 Peptide CDMO Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.1.2 Price Trend of Key Raw Materials
17.1.3 Key Suppliers of Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.2.1 Raw Materials
17.2.2 Labor Cost
17.2.3 Manufacturing Expenses
17.3 Manufacturing Process Analysis of Peptide CDMO
17.4 Peptide CDMO Industrial Chain Analysis
18 Peptide CDMO Industry Dynamic Analysis
18.1 Peptide CDMO Market Trends Analysis
18.2 Peptide CDMO Market Drivers Analysis
18.3 Peptide CDMO Market Challenges Analysis
18.4 Peptide CDMO Market Restraints Analysis
18.5 Peptide CDMO Market Technology Analysis
19 Market Channel, Distributors, Traders and Dealers
19.1 Market Channel Status
19.1.1 Direct Marketing
19.1.2 Indirect Marketing
19.2 Peptide CDMO Typical Distributors
19.3 Peptide CDMO Typical Customers
20 Research Findings and Conclusion